Calcineurin Inhibitor-Free Graft-Versus-Host Disease (GVHD) Prophylaxis in Hematopoietic Cell Transplantation (HCT) with Myeloablative Conditioning Regimens (MAC) and HLA-Matched Donors: Results of the BMT CTN 1301 Progress II Trial
2021
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI